Crossmark

Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review

Crossref DOI link: https://doi.org/10.1186/s12879-019-4500-7

Published Online: 2019-10-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ishihara, Ayaka

Hatakeyama, Shuji

Suzuki, Jun

Amano, Yusuke

Sasahara, Teppei

Toshima, Masaki

Morisawa, Yuji
License Information

Text and Data Mining valid from 2019-10-15

Version of Record valid from 2019-10-15
More Information

Article History

Received: 28 June 2019

Accepted: 24 September 2019

First Online: 15 October 2019

Ethics approval and consent to participate

: Not applicable.

: The parents of the patient provided written informed consent for publication of this report according to the patient’s consent given prior to death.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below